Literature DB >> 9344212

Terbinafine-induced acute generalized exanthematous pustulosis confirmed by a positive patch-test result.

A Kempinaire1, L De Raeve, M Merckx, A De Coninck, M Bauwens, D Roseeuw.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9344212     DOI： 10.1016/s0190-9622(97)70191-9

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  5 in total

1.  T-cell involvement in drug-induced acute generalized exanthematous pustulosis.

Authors:  M Britschgi; U C Steiner; S Schmid; J P Depta; G Senti; A Bircher; C Burkhart; N Yawalkar; W J Pichler
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

2.  [Acute generalized exanthematous pustulosis with confirmed type IV allergy. Report of 3 cases].

Authors:  K Gensch; N Hodzic-Avdagic; M Megahed; T Ruzicka; A Kuhn
Journal:  Hautarzt       Date:  2007-03       Impact factor: 0.751

Review 3.  Skin manifestations of drug reactions.

Authors:  James Q Del Rosso
Journal:  Curr Allergy Asthma Rep       Date:  2002-07       Impact factor: 4.919

Review 4.  Generalized pustular psoriasis and hepatic dysfunction associated with oral terbinafine therapy.

Authors:  Byung-Soo Kim; Ho-Sun Jang; Seung-Wook Jwa; Bong-Seok Jang; Moon-Bum Kim; Chang-Keun Oh; Yoo-Wook Kwon; Kyung-Sool Kwon
Journal:  J Korean Med Sci       Date:  2007-02       Impact factor: 2.153

Review 5.  The Role of Patch Testing in Evaluating Delayed Hypersensitivity Reactions to Medications.

Authors:  Carina M Woodruff; Nina Botto
Journal:  Clin Rev Allergy Immunol       Date:  2022-02-03       Impact factor: 10.817
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.